Cargando…

MARCH5-dependent degradation of MCL1/NOXA complexes defines susceptibility to antimitotic drug treatment

Cells experiencing delays in mitotic progression are prone to undergo apoptosis unless they can exit mitosis before proapoptotic factors reach a critical threshold. Microtubule targeting agents (MTAs) arrest cells in mitosis and induce apoptotic cell death engaging the BCL2 network. Degradation of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haschka, Manuel D., Karbon, Gerlinde, Soratroi, Claudia, O’Neill, Katelyn L., Luo, Xu, Villunger, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370223/ https://www.ncbi.nlm.nih.gov/pubmed/32015503 http://dx.doi.org/10.1038/s41418-020-0503-6

Ejemplares similares

The BH3-only protein NOXA serves as an independent predictor of breast cancer patient survival and defines susceptibility to microtubule targeting agents
por: Karbon, Gerlinde, et al.
Publicado: (2021)

The NOXA–MCL1–BIM axis defines lifespan on extended mitotic arrest
por: Haschka, Manuel D., et al.
Publicado: (2015)

Perturbing mitosis for anti‐cancer therapy: is cell death the only answer?
por: Haschka, Manuel, et al.
Publicado: (2018)

MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation
por: Arai, Seiji, et al.
Publicado: (2020)

MARCH5 requires MTCH2 to coordinate proteasomal turnover of the MCL1:NOXA complex
por: Djajawi, Tirta Mario, et al.
Publicado: (2020)

Inhibition of MARCH5 ubiquitin ligase abrogates MCL1-dependent resistance to BH3 mimetics via NOXA
por: Subramanian, Aishwarya, et al.
Publicado: (2016)

DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the Noxa/MCL-1/CDK2 complex
por: Nakajima, Wataru, et al.
Publicado: (2016)

The role of glucocorticoid receptor phosphorylation in Mcl-1 and NOXA gene expression
por: Lynch, James T, et al.
Publicado: (2010)

The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin
por: Geserick, P, et al.
Publicado: (2014)

The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin
por: Geserick, P, et al.
Publicado: (2015)

Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms
por: Nguyen, Tri, et al.
Publicado: (2018)

The PIDDosome activates p53 in response to supernumerary centrosomes
por: Fava, Luca L., et al.
Publicado: (2017)

Apoptosis induced by overall metabolic stress converges on the Bcl-2 family proteins Noxa and Mcl-1
por: Wensveen, Felix M., et al.
Publicado: (2011)

CDK1 Inhibition Targets the p53-NOXA-MCL1 Axis, Selectively Kills Embryonic Stem Cells, and Prevents Teratoma Formation
por: Huskey, Noelle E., et al.
Publicado: (2015)

Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa
por: Naik, Edwina, et al.
Publicado: (2007)

Photopharmacology of Antimitotic Agents
por: Kirchner, Susanne, et al.
Publicado: (2022)

Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer
por: Nakajima, W, et al.
Publicado: (2014)

AT101 [(-)-Gossypol] Selectively Inhibits MCL1 and Sensitizes Carcinoma to BH3 Mimetics by Inducing and Stabilizing NOXA
por: Mallick, David J., et al.
Publicado: (2020)

LiCl induces apoptosis via CHOP/NOXA/Mcl-1 axis in human choroidal melanoma cells
por: Zhang, Qiuqiu, et al.
Publicado: (2021)

Induction of Noxa-Mediated Apoptosis by Modified Vaccinia Virus Ankara Depends on Viral Recognition by Cytosolic Helicases, Leading to IRF-3/IFN-β-Dependent Induction of Pro-Apoptotic Noxa
por: Eitz Ferrer, Pedro, et al.
Publicado: (2011)

Genetic variants of NOXA and MCL1 modify the risk of HPV16-associated squamous cell carcinoma of the head and neck
por: Zhou, Ziyuan, et al.
Publicado: (2012)

The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA
por: Weller, Sandra, et al.
Publicado: (2022)

BH3-only protein Noxa contributes to apoptotic control of stress-erythropoiesis
por: Wensveen, Felix M., et al.
Publicado: (2013)

Antimitotic drugs in the treatment of cancer
por: van Vuuren, Rustelle Janse, et al.
Publicado: (2015)

Roscovitine-induced Apoptosis in Neutrophils and Neutrophil Progenitors Is Regulated by the Bcl-2-Family Members Bim, Puma, Noxa and Mcl-1
por: Gautam, Sanjivan, et al.
Publicado: (2013)

c-FLIP and the NOXA/Mcl-1 axis participate in the synergistic effect of pemetrexed plus cisplatin in human choroidal melanoma cells
por: Zhao, Xiaofei, et al.
Publicado: (2017)

The proliferation rate paradox in antimitotic chemotherapy
por: Mitchison, Timothy J.
Publicado: (2012)

Correction: Roscovitine-induced Apoptosis in Neutrophils and Neutrophil Progenitors Is Regulated by the Bcl-2-Family Members Bim, Puma, Noxa and Mcl-1
por: Gautam, Sanjivan, et al.
Publicado: (2014)

Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa/Bim/Mcl-1/p-Chk1 axis
por: Zhang, Jingyi, et al.
Publicado: (2022)

CHIP ubiquitylates NOXA and induces its lysosomal degradation in response to DNA damage
por: Albert, Marie-Christine, et al.
Publicado: (2020)

Noxa and Mcl-1 expression influence the sensitivity to BH3-mimetics that target Bcl-xL in patient-derived glioma stem cells
por: Vera, Mariana Belén, et al.
Publicado: (2022)

Effect of an antimitotic agent colchicine on thioacetamide hepatotoxicity.
por: Mangipudy, R S, et al.
Publicado: (1996)

Total Synthesis of the Antimitotic Marine Macrolide (−)-Leiodermatolide**
por: Paterson, Ian, et al.
Publicado: (2014)

Second-Generation Antimitotics in Cancer Clinical Trials
por: Novais, Pedro, et al.
Publicado: (2021)

Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells
por: Yan, J, et al.
Publicado: (2014)

Natural products as new antimitotic compounds for anticancer drug development
por: Paier, Carlos Roberto Koscky, et al.
Publicado: (2018)

BH3-only protein Bmf mediates apoptosis upon inhibition of CAP-dependent protein synthesis
por: Grespi, Francesca, et al.
Publicado: (2010)

The Antimitotic Action of an Aromatic Nitrogen Mustard on Tissue Cultures
por: Rinaldini, L. M.
Publicado: (1952)

Microtubule S-glutathionylation as a potential approach for antimitotic agents
por: Chen, Wei, et al.
Publicado: (2012)

Re-investigating PLK1 inhibitors as antimitotic agents
por: Delacour, Quentin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5airlmp0p8bq3b6dtam9ndmq3n